New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR)

Ads

You May Also Like

Chiasma Reports Second Quarter 2017 Results

WALTHAM, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

Oncobiologics Closes on Final Portion of $15 Million Senior Secured Note and Warrant Offering

CRANBURY, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...